反応式
Cl[C:2]1[CH:11]=[C:10]2[C:5]([C:6](=[O:17])[C:7]([C:14]([OH:16])=[O:15])=[CH:8][N:9]2[CH2:12][CH3:13])=[CH:4][C:3]=1[F:18].[CH3:19][CH:20]1[CH2:25][NH:24][CH2:23][CH2:22][NH:21]1.C(C(CCCC)C([O-])=O)C.[Na+:36]>C(OC(=O)C)C.C(Cl)(Cl)Cl>[Na+:36].[CH2:12]([N:9]1[C:10]2[C:5](=[CH:4][C:3]([F:18])=[C:2]([N:24]3[CH2:23][CH2:22][NH:21][CH:20]([CH3:19])[CH2:25]3)[CH:11]=2)[C:6](=[O:17])[C:7]([C:14]([O-:16])=[O:15])=[CH:8]1)[CH3:13]参加物
6
反応物 3
生成物 1
試薬・触媒・溶媒 2
実験手順
A mixture of 7-chloro-1-ethyl-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid [J. Med. Chem., 23, 1358 (1980)] (0.52 g, 2 mmol) and 2-methylpiperazine (0.8 g, 8 mmol) was heated at 175° for 5 hours. The residue was dissolved in ethylacetate (10 mL) and chloroform (10 mL), and a solution of sodium-2-ethyl- hexanoate (0.33 g, 2 mmol) in ethyl acetate (20 mL) was added. The mixture was stirred for 30 minutes and the precipitate was collected. The crude product was purified by preparative liquid chromatography (C-18 reverse phase, gradient 0-40% acetonitrile in water) to give a pale yellow lyophilized solid (0.5 g, 75% yield).
後処理
- temperaturewas heated at 175° for 5 hours
- customthe precipitate was collected
- customThe crude product was purified by preparative liquid chromatography (C-18 reverse phase, gradient 0-40% acetonitrile in water)
出典と根拠
- ORDレコード
- ord-f139f0669db54306a99a6acbf3f14bfb
- 出典データセット
- uspto-grants-1992_11
- 特許番号
- US05162523
関連ノート
読み込み中…